Moleculin Biotech (MOL) Q2 2024 Earnings Report
DE:MOL Q2 2024 EPS Results
- Actual EPS
- -EUR 761.09
- Consensus EPS
- -EUR 1,123.72
- Beat/Miss
- Beat by +EUR 362.64
- One Year Ago EPS
- -EUR 1,343.10
DE:MOL Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/14/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 14, 2024
DE:MOL Upcoming Earnings
Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:MOL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | 2.34 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -27.82-25.07 | -219.37 | 88.57% (+194.30) | |
| May 15, 2026 | 2026 (Q1) | -41.79-63.39 | -308.91 | 79.48% (+245.52) | |
| Mar 19, 2026 | 2025 (Q4) | -109.4846.74 | 111.92 | -58.24% (-65.18) | |
| Nov 17, 2025 | 2025 (Q3) | -5.89-15.24 | -63.8 | 76.12% (+48.56) | |
| Aug 13, 2025 | 2025 (Q2) | -192.51-219.37 | -761.09 | 71.18% (+541.72) | |
| May 14, 2025 | 2025 (Q1) | -248.47-308.91 | -904.35 | 65.84% (+595.44) | |
| Mar 24, 2025 | 2024 (Q4) | -574.55111.92 | -2247.45 | 104.98% (+2359.37) | |
| Nov 11, 2024 | 2024 (Q3) | -1092.39-1275.94 | -1275.94 | 0.00% (+0.00) | |
| Aug 14, 2024 | 2024 (Q2) | -1123.72-761.09 | -1343.1 | 43.33% (+582.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
